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Summary
Objective: An age-related decline in chondrocyte production of osteogenic protein-1 (OP-1) (Bone Morphogenetic Protein-7) may contribute to
cartilage loss in osteoarthritis. This study was designed to determine if increased methylation of the OP-1 promoter might serve as a mech-
anism for the age-related decline in OP-1 expression.
Methods: Human articular chondrocytes were isolated from cartilage obtained after death from tissue donors (ages 19e86 years) without
a known history of arthritis. DNA was obtained from isolated chondrocytes in primary culture and analyzed for OP-1 promoter methylation
by polymerase chain reaction (PCR) after bisulﬁte treatment. Cultured cells were treated with the DNA methyltransferase inhibitor 5-azacyti-
dine and OP-1 production was measured in the media by enzyme-linked immunosorbent assay (ELISA). RNA was isolated to measure ex-
pression of insulin-like growth factor-1 (IGF-1), the IGF-1 receptor (IGF-1R), aggrecan, and OP-1 by real-time PCR.
Results: Methylation of the OP-1 promoter was detected in chondrocytes isolated from tissue obtained from older adults and there was
a positive correlation between age and OP-1 methylation status (n¼ 22, R2¼ 0.277, P¼ 0.014). Inhibition of methylation in cultured cells
with 5-azacytidine increased chondrocyte production of OP-1 protein and increased the expression of the IGF-1, the IGF-1R, aggrecan,
and OP-1 genes but not GAPDH.
Conclusion: Age-related methylation of the OP-1 promoter may contribute to a decrease in OP-1 production in cartilage and a decrease in
expression of OP-1 responsive genes such as IGF-1, the IGF-1R, and aggrecan.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The loss of articular cartilage that is a characteristic
feature of osteoarthritis (OA) is strongly associated with
aging but the mechanisms by which aging contributes to
the development of OA are not completely deﬁned1. Since
chondrocytes are responsible for both the synthesis and
breakdown of the articular cartilage, processes which
cause chondrocytes to exhibit either decreased matrix
synthesis and/or increased production of matrix degrading
enzymes will lead to cartilage loss. Growth factors, includ-
ing insulin-like growth factor-1 (IGF-1) and osteogenic
protein-1 (OP-1), are important regulators of chondrocyte
anabolic activity and so alterations in the levels or activity
of these growth factors with aging could contribute to an
imbalance in matrix synthesis and degradation.aThese authors contributed equally to this work.
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513Aging has been associated with a decline in levels of
growth factors. Although systemic levels of IGF-1 decline
with aging, studies to date have not determined if IGF-1
levels in cartilage change with age. However, about a four-
fold reduction in the level of OP-1 in cartilage has been ob-
served in adult humans between the ages of 35 and 75
years2. This was correlated with an age-related reduction
in OP-1 RNA levels suggesting reduced OP-1 gene tran-
scription with aging. An age-related reduction in the chon-
drocyte synthetic response to IGF-1 has been observed3,4
while the synthetic response to OP-1 with aging has not
been determined. Importantly, chondrocytes from older
adults and from OA cartilage respond better to a combina-
tion of IGF-1 and OP-1 in terms of matrix synthesis5,6 and
inhibition of stimulated matrix metalloproteinase expres-
sion7. In the latter study, evidence was provided for a stimu-
latory effect of OP-1 on IGF-1 and IGF-1R expression
indicating that an age-related loss of OP-1 could potentially
have a negative effect on the IGF-1 system in cartilage.
The present study was undertaken in order to determine
the mechanism for the age-related reduction in expression
of OP-1 by chondrocytes. Recent studies have demon-
strated the importance of epigenetic regulation of gene tran-
scription, including the role of DNA methylation which can
Table I
Primer sequences for real-time PCR
Gene Primer sequences (forward/reverse) (50e30) Size (bp) Annealing
temperature ((C)
Reference
accession no.
GAPDH TCGACAGTCAGCCGCATCTTCTTTGCCCAATACGACCAAATCCGTTGA 148 55 EMBL:NM_002046
Aggrecan TCTTGGAGAAGGGAGTCCAACTCTACAGCTGCAGTGATGACCCTCAGA 89 55 EMBL:NM_013227
IGF-1 TGGTCCTGGAGTTGGTAGATTGCTCACCCATGCATTTGTGGCTCTTGA 124 55 NM_000618.2
IGF-1R TGATCCTGGATGCGGTGTCCAATATGGTCTTCTCACACATCGGCTTCT 111 55 NM_000875.3
OP-1 AGGGCTGGCTGGTGTTTGACATAGAGCTGCAGGCCCAGGTTGT 81 58 NM_001719.1
514 R. F. Loeser et al.: Methylation of the OP-1 promoterbe altered with aging8. DNAmethyltransferases serve to reg-
ulate transcription of speciﬁc genes through the methylation
of cytosine residues most commonly found in a 50-CG-30 or
the ‘‘CpG’’ conﬁguration. We noted that the OP-1 promoter
hasa largenumber ofCpG rich regions, including27CGpairs
in the ﬁrst 250 bp 50 to the transcription start site, and so set-
out to test the hypothesis that increased methylation of the
OP-1 promoter with aging could be responsible for the age-
related reduction in OP-1 expression.MethodsTISSUE ACQUISITION AND CELL CULTUREIn order to study normal tissue and avoid the potential effects of degener-
ative changes or OA, which are very common in the knees of older adults,
normal articular cartilage was obtained from the ankle joints (talus) of approx-
imately 31 tissue donors through the Gift of Hope Organ and Tissue Donor
Network (Elmhurst, IL). Tissue was also obtained from the knee joint of three
donors in order to do limited ankle-knee comparisons. The donors had no
known history of arthritis. Each joint was graded on a modiﬁed Collin’s scale10 20 30 40 50 60 70 80 90
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Fig. 1. Age-related increase in methylation of OP-1 promoter DNA.
(A) Methylation speciﬁc PCR for OP-1 using DNA isolated from cul-
tures of young (20 years old) and old (74 years old) donor chondro-
cytes. DNA was ampliﬁed using primers recognizing sequences
corresponding to methylated and unmethylated regions of bisulﬁte
treated DNA. Samples with H2O substituted for DNA were used
as a control to exclude primeredimer formation. (B) Relationship
of age to OP-1 promoter methylation status. The graph shows the
ratio of PCR products obtained using the methylation speciﬁc
primers normalized to results with primers from the unmethylated
region (n¼ 22, R2¼ 0.277, P¼ 0.014).(0e4) for gross evidence of damage as described9. Only normal or nearly
normal ankle tissue (grade 0 or 1) was used while the knee tissue from
one donor was grade 2. Cartilage was dissected from the talus of the ankle
joint or from the femur of the knee joint and cells were isolated by enzymatic
digestion as previously described5. Chondrocytes were cultured in high den-
sity monolayers for 96 h in the presence of 10% fetal bovine serum prior to
DNA isolation for methylation speciﬁc polymerase chain reaction (PCR). In
other experiments, freshly isolated chondrocytes were cultured for 120 h in
media with 10% serum in the presence of 0e10 mM 5-aza-20-deoxycytidine
(5-azacytidine) (SigmaeAldrich, St. Louis, MO) in order to inhibit DNA meth-
ylation10. We chose to treat the cells for this time period because, based on
our experience with cultured human chondrocytes, this is the time when the
cells will proliferate in monolayer culture after isolation and proliferation is
necessary for optimal inhibition of DNA methylation by 5-azacytidine.ANALYSIS OF OP-1 PROMOTER METHYLATIONOP-1 promoter methylation was quantitated using methylation speciﬁc
PCR with DNA collected from the short-term (96 h) high density monolayer
cultures. We were not able to design the primers for traditional bisulﬁte se-
quencing PCR due to the GC-rich sequence of the OP-1 promoter (62%
GC). The following primers, interrogating four CG pairs, were designed to hy-
bridize with CG pairs only if methylated:
Forward (46 to 21): 50GGT TTG TTG GTTGTT TTT TTT ATT C30
Backward (þ75 to þ100): 50CGA ACC CCC GCC CCC TAC TCG ATA
C30.
DNA was treated with sodium bisulﬁte as previously described11, ampli-
ﬁed with the primers, and the product quantitated using real-time PCR on
a Corbett Rotor-Gene real-time PCR unit (Corbett Life Sciences, Mortlake,
Australia). Results were standardized to loading controls, consisting of sim-
ilar ampliﬁcation of an adjacent sequence lacking CG pairs:
Forward (824 to 800): 50AAT TTT AGT TTG GTA GGT TTT GGA G 30
Backward (391 to 366): 50 ATC TTA CCC CTC AAT CCC TAT ATC 30.OP-1 ELISAOP-1 was measured in media samples from cells treated with 5-azacyti-
dine using an ELISA previously described in detail2. This chemiluminescent0
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Fig. 2. Treatment of chondrocytes with 5-azacytidine (0e10 mM) in-
creases the production of OP-1. An ELISA was used to measure
OP-1 levels in the media from cells of two different donors aged
72 and 80 years. OP-1 results were normalized to the DNA content
measured in the cell-layer. *P< 0.001 vs control.
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Fig. 3. Effects of 5-azacytidine on chondrocyte gene expression. Primary chondrocytes isolated from donors with ages of 71e82 years were
treated in culture with the indicated doses of 5-azacytidine for 120 h. RNA was isolated and used for real-time PCR with primers speciﬁc for
IGF-1, the IGF-1R, OP-1, aggrecan, or GAPDH as a control. (AeD) Results using cells cultured from the ankle joint (n¼ 6) and (E) a compar-
ison of cells cultured from ankle (n¼ 7) and knee cartilage (n¼ 2). *P< 0.05.
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516 R. F. Loeser et al.: Methylation of the OP-1 promoter(Supersignal ELISA Femto Maximum Sensitivity Substrate from Pierce,
Rockford, IL) sandwich ELISA uses two antibodies to OP-1 for detection
and puriﬁed human recombinant OP-1 (Stryker Biotech, Hopkinton, MA) as
standard and is sensitive down to the pg/ml range of OP-1. The data, ex-
pressed as relative light units, were obtained using a chemiluminescent
ELISA plate reader. ELISA assays were performed in quadruplicate and re-
sults were normalized to the total DNA in each sample well measured using
the picogreen assay as previously described5.REAL-TIME PCR FOR IGF-1, IGF-1 RECEPTOR (IGF-1R), OP-1,
AND AGGRECANTotal cellular RNA was isolated using the RNeasy Mini kit (Qiagen). Re-
verse transcription (RT) was carried out with 2 mg total cellular RNA using the
ThermoScript RT-PCR System (Invitrogen, Carlsbad, CA) for the ﬁrst
strand cDNA synthesis. The cDNA was ampliﬁed using the MyiQ Real-
Time PCR Detection System (Bio-Rad, Hercules, CA). Relative mRNA
expression was determined using the DDCT method, as detailed by the man-
ufacturer’s guidelines (Bio-Rad). GAPDH was used as a control and was not
observed to change with the treatments tested. The primer sequences used
are listed in Table I.Results
OP-1 DNA methylation was evaluated using DNA sam-
ples from untreated chondrocyte cultures analyzed by
methylation speciﬁc PCR, using primers designed for the
OP-1 promoter. This revealed methylated DNA in articular
chondrocyte samples isolated from a 74-year-old tissue
donor but not in a chondrocyte DNA sample from a 20-
year-old donor [Fig. 1(A)]. In contrast, primers speciﬁc for
unmethylated DNA ampliﬁed the sample from the young
donor and resulted in a weak band in the sample from
the old donor [Fig. 1(A)] but the primers tested were not
found to give consistent and reliable results. Therefore,
only methylation speciﬁc primers were used for further
analysis. Samples of articular chondrocyte DNA from an
additional 20 normal appearing ankle joints were analyzed
and, as expected with human samples, there was hetero-
geneity in the levels of OP-1 promoter methylation but
a positive correlation between age and the ratio of methyl-
ated to unmethylated DNA was found [Fig. 1(B)].
Chondrocyte cultures from 72-year-old and 80-year-old
donors, treated with 0e10 mM 5-azacytidine, were used to
measure OP-1 production by ELISA. There was a dose de-
pendent increase in OP-1 production indicating that inhibi-
tion of DNA methylation resulted in increased OP-1
expression (Fig. 2). This was further tested by treating cells
from six additional older (71e82 years) donors and measur-
ing RNA levels by real-time PCR with primers speciﬁc for
OP-1 and aggrecan, as well as IGF-1 and the IGF-1R,
genes we had previously shown7 were regulated by OP-1.
Treatment with 5-azacytidine increased expression of IGF-
1, the IGF-1R, OP-1 and aggrecan [Fig. 3(AeD)]. Chondro-
cytes also obtained from the knee joints of two donors were
compared to those from ankle joints and similar effects of 5-
azacytidine on IGF-1 and OP-1 expression were observed
[Fig. 3(E)].Discussion
To our knowledge this is the ﬁrst report of DNA methyla-
tion in the OP-1 (Bone Morphogentic Protein-7) promoter.
The ﬁnding that OP-1 promoter methylation was increased
in cells from older adults and that inhibition of methylation in
cultured cells increased OP-1 expression are consistent
with our hypothesis that increased OP-1 promoter methyla-
tion can be responsible for an age-related decrease in OP-1
expression previously found in chondrocytes2. BecauseOP-1 is a potent anabolic growth factor for articular chon-
drocytes5,12, an aging-related increase in OP-1 promoter
methylation that leads to decreased expression may con-
tribute to cartilage loss seen with aging and in particular
with the progression of OA in older adults.
Although there is accumulating evidence that altered
DNA methylation may contribute to the aging phenotype8,13,
very few studies have examined the role of DNA methyla-
tion in the regulation of chondrocyte gene expression14.
Changes in DNA methylation were not found to directly reg-
ulate aggrecan expression in normal aged or OA carti-
lage15. However, Roach et al.16 reported that a decrease
in the methylation of promoter sites in several matrix
degrading enzymes (matrix metalloproteinase-3 (MMP)-3,
MMP-9, MMP-13, and a disintegrin and metalloproteinase
with thrombospondin motifs (ADAMTS)-4) could be de-
tected in OA chondrocytes. Similar to our ﬁndings, this latter
study also noted a high degree of variability in promoter
methylation in both the normal older adult cartilage samples
and the OA samples.
It is not unexpected to ﬁnd that some promoters exhibit
increased methylation while others are decreased in the
same cell-type or even the same disease state since multi-
ple factors control methylation of speciﬁc promoters. These
factors include interactions of the promoters with transcrip-
tion factors which may inﬂuence subsequent methylation or
demethylation. For example, it is possible that demethyla-
tion of the MMP promoters observed in OA chondrocytes
is related to cytokine-stimulation of NFkB14 which can
bind MMP promoters but would not be expected to interact
with the OP-1 promoter. In addition, regional modiﬁcation of
histones may also play a role17.
Another interesting ﬁnding in the present study was that
IGF-1, IGF-1R, and aggrecan RNA levels appeared to in-
crease after inhibition of DNA methylation. Although these
cells do not produce enough IGF-1 in culture to measure
IGF-1 protein levels (unpublished observation), the ﬁnding
was reproducible at the RNA level in cultures established
from six older donors. Although we did not examine the
IGF-1 promoter using methylation speciﬁc PCR, the effect
was not likely due to a direct effect of demethylation of
the IGF-1 promoter since it does not contain CpG islands.
Because OP-1 can upregulate IGF-1 expression, as well
as IGF-1R and aggrecan expression, it is possible that
the increase in all three after 5-azacytidine treatment was
due to stimulation by OP-1. Further studies will need to
be performed to investigate the mechanism and conse-
quences of OP-1 promoter methylation in chondrocytes.
This work could provide important information needed to
understand the link between aging, reduced growth factor
activity in cartilage, and the development of OA.Conﬂict of interest
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